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Introduzione/Obiettivo 
 
Preeclampsia (PE) is a severe pregnancy-related syndrome characterized by 
exacerbated placental inflammation. LMWH has been used during PE since several 
trials described its anti-inflammatory effect. Nevertheless, LMWH mechanisms of 
action on the placental tissue are still unclear. HMGB1 is a transcription factor with 
an extracellular cytokine-like function that plays a pivotal role in the inflammatory 
process. HMGB1 bound to its receptor RAGE (Receptor for Advanced Glycation End 
products) is able to induce the transcription of the pro-inflammatory cytokine TNF-α 
and IL-6. LMWH binds to HMGB1 in-vitro, thus changing its structural conformation 
and inhibiting its activity. Since HMGB1 has been previously found up-regulated in 
PE, in the present study we investigated LMWH’s modulation of HMGB1/RAGE axis 
and its targets TNF-α and IL-6 in the placental tissues 
 
Materiali e metodi 
Human placental villous explants (n=32) were excised from physiological placentae 
(n=4), cultured in HAM F12 medium and treated for 24h by LMWH 0.5 units (U; 
Parnaparin, Alfa Wassermann, Italy) or plain culture medium (controls). HMGB1, 
TNF-α and IL-6 mRNA expression was assessed by Real Time PCR while HMGB1 and 
RAGE protein expression was determined by Western Blot assay. HMGB1/RAGE 
binding affinity was assessed by RAGE immunoprecipitation (IP) followed by HMGB1 
immunoblot performed on the resulting pellets and RAGE-deprived placental 
lysates. 
 
Risultati 
We reported significantly decreased gene expression levels of HMGB1 and TNF-α 
(p&lt;0.05, 2.45 and 1.85 Fold Decrease) and a markedly decreased IL-6 (1.27 Fold 
Decrease) in placental villous explants treated by LMWH 0.5U vsuntreated controls. 
In contrast, HMGB1 protein levels were increased (p=0.044, 2.13 Fold Increase), 
while no differences in RAGE protein levels were found in placental villous explants 
treated by 0.5U LMWH compared to untreated controls (p&gt;0.05). Finally, HMGB1 
significantly decreased in the IP pellet (p=0.022, 1.60 Fold Decrease) and it increased 
in the RAGE-deprived lysates (p=0.003, 4.45 Fold Increase) of LMWH-treated villous 
explants compared to controls. 
 
Conclusioni 
Herein, we described a direct effect of LMWH on placental HMGB1/RAGE axis 
modulation. Indeed, HMGB1 protein increase accompanied by decreased HMGB1, 
TNF-α and IL-6 gene expression level in LMWH-treated villous explants confirm the 
anti-inflammatory effect of heparin and it suggest an impairment of HMGB1 
extracellular functions. Indeed, HMGB1 in the LMWH-treated placental lysates after 
RAGE IP strongly suggest an heparin-mediated HMGB1 conformation change able to 
diminish its affinity for RAGE, as previously demonstrated in other systems. Our 
study provides new important insights on the LMWH’s anti-inflammatory effect 
observed in PE women. 
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